Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hands-On therapy may ease period pain and improve C-Section scar mobility

NCT ID NCT07717983

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Aug 05, 2026 · Updated 6 times

Summary

This trial investigates whether adding a hands-on technique called abdominopelvic fascial release to stretching exercises can reduce menstrual pain and improve scar mobility in women who have had a cesarean section. The study enrolls women aged 20 to 35 with moderate to severe period pain and restricted scar movement. Participants are randomly assigned to receive either the fascial release plus stretching or stretching alone over two weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
abdominopelvic fascial release, a manual therapy technique applied by a physiotherapist
What this could lead to
If effective, this approach could offer a non-drug option for managing menstrual pain and improving scar mobility after cesarean delivery.
What could go wrong
This is a small, early-stage trial with only 58 participants, so results may not apply widely. The therapy is manual and depends on the practitioner's skill, which could affect consistency.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 58 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Females aged 20 to 35 years. * History of at least one cesarean section. * Moderate to severe primary or secondary dysmenorrhea following cesarean section. * Regular menstrual cycles (21-35 days). * Body mass index (BMI) between 18.5 and 29.9 kg/m². * At least 6 months post-cesarean section to allow complete scar healing. * Presence of restricted cesarean scar mobility on clinical examination. * Willingness to participate and provide written informed consent. Exclusion Criteria: * Pregnancy or planned pregnancy during the study period. * Previous abdominal or pelvic surgery other than cesarean section. * Endometriosis, adenomyosis, uterine fibroids requiring treatment, or other diagnosed gynecological disorders associated with pelvic pain. * Active pelvic inflammatory disease or genitourinary infection. * Neurological or musculoskeletal disorders affecting pain perception or mobility. * Systemic inflammatory, autoimmune, or connective tissue diseases. * Current participation in another physical therapy or manual therapy program targeting the abdomen or pelvis. * Use of corticosteroid injections or other invasive treatments to the abdominal or pelvic region within the previous 3 months. * Contraindications to manual therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dysmenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean section Dysmenorrhea Dysmenorrhea, cesarean section, postoperative adhesions Postoperative adhesions

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.